This review compares droplet-based microfluidic systems used to study crystallization fundamentals in chemistry and biology. An original high-throughput droplet-based microfluidic platform is presented. It uses nL droplets, generates a "chemical library"
I. INTRODUCTION
Crystallization is used in chemistry and biology for molecule separation, purification processes, for control of product properties and for analytical purposes (1). For instance, protein crystallization is a key step in the determination of the threedimensional structure of proteins by X-ray diffraction (XRD), allowing a better understanding of their biological functions (2). In pharmaceutical applications, there may be a wide variety of solid forms may appear such as polymorphs, solvates, microcrystalline solids and amorphs (3) . Crystal properties are influenced by many parameters such as temperature, solute concentration, chemical composition and hydrodynamics.
In crystallization from solution, the first step, nucleation, is fundamental in determining the physical properties of crystals, such as size distribution and phases (4) . However, nucleation is a stochastic phenomenon requiring numerous experiments to obtain reliable data (5, 6) .
Crystallization studies are generally performed in milli-or micro-reactors (5, 7, 8) .
However, using these large volumes has two drawbacks: first, the crystals need to be located in space and in time in order to follow their formation. Second, a large quantity of raw material is required for statistics to obtain reliable data.
The unpredictability of nucleation can be addressed by reducing the volume of crystallization, making observation possible at the micrometer scale, and thus increasing the resolution of detection with an optical microscope, for instance.
Moreover, identifying the conditions required to obtain crystals usually involves screening crystallization conditions and then optimizing one of them. This volume reduction is particularly advantageous with molecules that are expensive to produce and of limited availability. However, reducing the volume of reactors considerably increases the surface/volume ratio of the solution and the effect of evaporation becomes non-negligible.
One way to control evaporation is to surround each small reactor with a non-miscible liquid, as in micro-emulsions, and/or with non-porous solids, as in micro-channels, and/or with gels of well-controlled micro-porosity. In the past decade, microfluidic tools to control and manipulate flows at sub-millimeter scale, have increasingly been used in a lab-on-chip approach (9) . This has allowed the number of experiments to be increased and the amount of material to be decreased (9) (10) (11) . Microfluidics holds great promise for the control and the study of crystallization processes, for instance, producing crystals of controlled size (12) . A very large number of microfluidic systems dedicated to the screening of crystallization conditions is available, based on different crystallization methods (2): free interface diffusion (13, 14) , counter diffusion (15, 16) , vapor diffusion (17, 18) , batch (19, 20) .
The present review covers droplet-based microfluidic crystallization techniques, which are generally miniaturized versions of the micro-batch method, i.e. mixing the solution containing the molecule of interest with solvent or buffer and/or anti-solvent and/or crystallization agent inside droplets generated in oil (21) (22) (23) (24) . In addition to technical considerations, this review focuses on their contribution to crystallization fundamentals: nucleation studies, screening and optimizing crystallization conditions, determining phase diagrams and studying polymorphism and structure of crystals.
II. DROPLET-BASED MICROFLUIDIC SYSTEMS
Various droplet-based microfluidic systems for crystallization studies are aimed at competing with high-throughput robots to screen crystallization conditions of biomolecules (proteins or active pharmaceutical ingredients). Thus, the microfluidic chip displays many integrated functions involved in automatized and complex manipulations of fluids, as in the platform developed by Perry et al. (14) (Figure 1 ).
This means that droplet-based microfluidic systems offer the advantages of highthroughput, low sample and reagent consumption, rapid mixing and minimal crosscontamination. However, despite the spectacular achievements in crystallization obtained thereby, several drawbacks remain.
1. These microfluidic chips rely mainly on microfabrication technologies such as softlithography, high-resolution stereo-lithography and 3D print techniques. Most chips are for single use and require complex equipment (integrated valves and pumps, mixers, especially designed and micro-fabricated micro-channels or chambers, multiple arrivals of pressurized gas). However, microfabrication processes can be expensive and time-consuming, requiring specialist infrastructure and extensive handling.
2. Currently used chip materials such as silicone (25), glass (25), hydrogels (26) and elastomers (27, 28) are not fully compatible with all crystallization solvents. For example, PDMS (polydimethylsiloxane), the most frequently used material, is not compatible with organic solvents such as acetone. Moreover, solvent may evaporate due to the permeability of the polymer.
3. The imposed channel network geometry makes it difficult to modify the setup, rendering it less accessible to non-specialists.
4. Liquid-handling at microfluidic scale is very sensitive to liquid properties such as flow viscosity and surface tension. Hence, system calibration is obligatory for each working fluid. This can be very difficult when handling liquids with high viscosity (i.e. PEG (polyethylene glycol)) or low surface tension (i.e. detergent used for solubilization of membrane protein). It is also the main reason why most of the current droplet methods rely on surfactant use. However, surfactants can interfere with the solute molecules, which affects crystallization.
To address these drawbacks, we developed a platform using commercially available and combinable modules (21, (29) (30) (31) (32) , rendering the setup easy to use for nonspecialists in microfluidics. The junctions and the tubing used to generate droplets are compatible with almost all solvents, showing excellent resistance and no solvent evaporation (31) . In addition, mixing of liquids, detection of droplets and their concentration and storage are performed independently, so the platform is flexible (Figure 2) . It is used to investigate crystallization of various molecules: proteins in aqueous and viscous solutions like lysozyme (21, 22, (29) (30) (31) 33) , rasburicase (23) and human quinone reductase 2 (QR2) (30, 32) , organic molecules like caffeine in isonicotinamide (21) , glyclazide in isopropanol and paracetamol in water, in acetonitrile and in isopropanol (34) .
All crystallization applications require crystals of suitable quality and size. The major challenge lies in monitoring and controlling the crystallization process. As no theory is available to predict in which environment or under what conditions a new molecule can successfully be crystallized, two steps are generally followed: screening for favorable crystallization conditions and subsequent optimizing of crystal growth. Moreover, for each experimental condition, droplets generated as nano-reactors have to be homogeneous (in composition, size and frequency). In the following, droplet-based microfluidic systems are compared in terms of generation of homogeneous droplets to determine the phase diagram, study polymorphism, screen and optimize crystallization conditions for crystal structure analysis.
III. DROPLETS AS NANO-REACTORS FOR CRYSTALLIZATION STUDIES
In crystallization studies, the solute is generally mixed with one component and/or gradients of concentration are generated. In droplet-based microfluidic systems, the channel is filled with different batches of mono-concentrated droplets, the chemical composition being varied using a multi-channel syringe pump and controlling the relative flow rates of the different solutions upstream of the junctions. Depending on the flow rate, droplets of different chemical compositions are generated. As suggested by Li et al. (9) , droplet composition is linked to size and frequency. Therefore, controlling size and frequency is key in microfluidic systems.
III.1. Controlling size and frequency of droplets:
Droplets of the liquid containing the solute are generated by injecting it (dispersed flow) together with a non-miscible liquid (continuous flow) into junctions. Many experiments and simulations investigate the size (length L) and frequency of droplets through phase properties (viscosity (35) (36) (37) (38) (39) (40) (41) (42) (43) and interfacial energy (35, 36, 43) ), channel geometry (the height and the width of the channels essentially in planar geometries with rectangular cross-sections (34, (40) (41) (42) 44) ) and operating parameters (flow rate ratio (35) (36) (37) (38) (39) (40) (41) (45) (46) (47) (48) ). Few studies deal with cylindrical channels.
In a cross-junction mixing two dispersed flows, an interface is observed in the droplet while it forms (29) (Figure 3a) . The two dispersed flows can be assumed to be Newtonian. As flows are laminar and convection-free due to negligible gravity (49), mixing proceeds solely by diffusion at the interface. Mixing time inside droplets is described by tmix = stl 2 /2D, where stl is the striation length, correlated with W the tubing inner diameter and D the diffusion coefficient (50) . Mixing in droplets after their breakup is accelerated by droplets twirling (46) with the continuous flow, however only when droplets are spherical. Figure 3b shows that the mixing time is 4-fold longer in elongated droplets (L>>W) (Figure 3b1 ) than in spherical ones (L=W) (Figure 3b2) .
Hence, droplet size should be determined by the specific objective of the crystallization: optimal crystal quality requires a long diffusion time and a convection-free medium, which means elongated droplets (L/W>2); screening of crystallization conditions requires complete and rapid mixing, which means small droplets (1<L/W<2). Note that droplets smaller than the tubing inner diameter (L/W<1) are mobile in the tubing and risk coalescing.
Another crucial factor is droplet frequency fD (number of droplets per s -1 ). Relatively low fD is required to reduce droplet coalescence and contamination when there is precipitation. However, high-throughput gradient screening and optimization trials involve the formation of a large number of droplets in long tubing, with high values of f (number of droplets per cm). This is very challenging because droplets are unstable and tend to collapse while circulating in long tubing, due to the non-negligible hydraulic resistance.
In a T-junction, important parameters for droplets generation include the flow-rates of continuous and dispersed flows represented respectively by their mean velocities vD and vC, the continuous flow viscosity µC and the interface tension between dispersed and continuous flows CD. We take into account these flow properties by using the capillary number Ca ( = × ). In addition, we identify an important new parameter vTOT, the sum of vD and vC. Droplet generation is similar for similar values of Ca, leading to different regimes: a steady regime with low risk of droplet coalescence for Ca < 0.2.
By contrast, the regime observed at Ca > 2 leads to high mobility of droplets in the tubing and thus a risk of coalescence (49) . Consequently, whatever the junction used, we first adjust the viscosity and the velocity of the continuous flow to maintain Ca < To reduce the consumption of material and use a wide range of solvents, the tubing can be filled directly, instead of using a syringe (20, 30) . To do so, tubing of the selected length is first filled with the continuous flow (to avoid contaminating the solutions) and then refilled with the liquid of interest. Then the solutions are successively injected into the microfluidic system to form droplets (9) . For instance, a length of 15cm of 150μm ID tubing contains ∼2.7μL, corresponding to about 900 droplets of 3nL. Consequently, using plugs instead of syringes considerably reduces the consumption of materials. The length of the plugs, and thus their volume, depends on the number of droplets required by the user.
III.3. Mixing components with the solution of interest
To add one or several components to a liquid containing the solute in a droplet-based microfluidic system, flows are either mixed directly with the solute flow in a multiport junction, or injected into droplets generated from the solute. Mixing aqueous solutions (30) with high viscosity and/or low interfacial energy (32) is possible using operating parameters (see part III.1) and droplet concentration is verified with an on-line spectrophotometer.
In the case of organic solvent mixed with water in a cross-junction, droplets generated in a continuous flow (oil) quickly coalesce, especially since no surfactant is used to stabilize them. We suggest that this is due to the interfacial energy CD, which is higher for the oil-water interface than for the oil-organic interface (30) . Thus, mixing the aqueous solution and the organic solvent first creates an interfacial energy gradient with oil, between the organic solvent-rich areas and the water-rich areas (before homogenization). This variation of the interfacial energy probably leads to a Marangoni flow. The result is a disturbance in the movement of generated droplets, causing their coalescence, as previously shown in the case of the addition of a surfactant (52).
Moreover, once the droplets are homogeneous, their interfacial energy with the tubing wall is much lower than for purely aqueous droplets. Hence droplets tend to wet the tubing wall, also promoting their coalescence. Consequently, it is impossible to add a pure organic solvent to water without disturbing the flow of generated droplets.
To reduce the effects of interfacial energy changes, we replaced the organic solvent by a mixture of organic solvent and water (30) . Different proportions of water were tested with various organic solvents and the addition of water clearly improved the stability of the generated droplets. However, the proportion of water required for this stabilization varies from one organic solvent to another. This proportion is correlated to a threshold value of CD, in the range 15-20mJ.m -2 , below which the droplets are not stable in the tubing. This value is very close to the critical surface energy of Teflon, 18mJ.m -2 (30), which represents the maximum interfacial energy of a liquid that wets the surface. Since the surface (in FEP (fluorinated ethylene propylene)) of the tubing is chemically similar to that of Teflon, this confirms that the droplets become unstable and tend to coalesce when they wet the tubing wall.
IV. FUNDAMENTALS OF CRYSTALLIZATION-THE PHASE DIAGRAM
Controlling 
IV.1. The solubility curve
In crystallization from solution, the first step consists in dissolving a chemical species in a solvent. When the concentration in the solution is greater than the solubility of the species in the solvent at the considered temperature, the solution is supersaturated and a solid phase can crystallize. Measuring the solubility curve is a crucial step in crystallization studies and process development. Therefore, all methods are based on measuring the concentration of a saturated solution. For instance, attenuated total reflection -Fourier transform infrared (ATR-FTIR) (55, 56) and Raman (57) spectroscopies were reported for in-situ solubility measurements. Raman spectroscopy was used by Laval et al. with a microfluidic setup for rapid screening of the solubility of an organic solute (58, 59) . Moreover, as previously pointed out, microfluidic experiments involve dissolving large quantities of material in a given volume until saturation.
To reduce the quantity of material consumed, our answer is to generate saturated solutions directly from powder in the microfluidic tubing ( Figure 5 ) (34) . The solvent flows through a powder bed blocked by a filter. At the outlet of the filter, due to the molecule dissolving, the solution concentration is at saturation. To avoid calibration of absorbance, which consumes additional material, a dilution step is added (Figure 5a) and the diluted solution is analyzed by an on-line UV-Vis spectrometer (Figure 5b ).
The two columns and the T-junction are placed in a temperature-controlled incubator, from room temperature to 65°C (Figure 5c ) (23) .
We applied this method to measure solubility in different solvents, using paracetamol as a model compound (34) . In Figure 6a -c, we compared our results with measurements realized in large volumes by various techniques (60) (61) (62) (63) (64) (65) (66) . Solubility data were consistent, showing the versatility, the reliability and the solubility range accessible with our technique. We also performed solubility measurements for glyclazide from TES (Figure 6d ) (34) . Data were consistent with measurements in large volumes (67) . The very good reproducibility confirmed our method's accuracy in concentration and temperature. Thus, our device rapidly measures he entire solubility curve at a variety of temperatures ranging from 20 to 60°C using extremely small quantities of material (3-30mg), with a concentration range from mg/mL to hundreds of mg/mL
IV.2. Metastable zone and phases occurrence
The metastable zone (MZ) is the temperature range within which the supersaturated solution can remain for the required time without losing its metastability (68) . Figure 7 shows that the minimum temperature (TMZ) defines two zones where nucleation and growth are kinetically or thermodynamically promoted, respectively. It must be noted that the nucleation corresponds to the appearance of crystals and growth to their subsequent expansion. Moreover, growth of crystals is optimal in the MZ, at low supersaturation, where nucleation is kinetically inactive. Crystal growers therefore aim to separate nucleation and growth phases.
As nucleation is a stochastic phenomenon, the probability of observing the first nuclei is very low, for spatial and temporal reasons. Nucleation can, however, be induced in the MZ, using external fields (6, 54, 69) which enable the timing of the nucleation event to be controlled. Controlling where nucleation occurs is possible by confining the nucleation volume using small droplets in microfluidic systems. Moreover, confinement makes it possible to dissociate crystal nucleation from growth, allowing nucleation to be studied and controlled.
IV.2.1. Measuring the metastable zone width
In practice, TMZ, at which there is no crystal for a given concentration, needs to be determined. To do so, droplets are stored at different temperatures T for the same time, long enough for the crystals to nucleate and grow, which depends on growth rate.
During this time if T < TMZ, crystals nucleate and if T > TMZ, no crystals appear. For a given concentration, the TMZ, at which there is no crystals, is the corresponding temperature on the metastable zone limit MZL (Figure 7) . We applied the method described in Figure 7 to measure the MZL for lysozyme in an aqueous solution (22) ( Figure 7a ) and for caffeine in ethanol (21) (Figure 7b ). Determining the MZL is a key step in nucleation studies. In addition, the nucleation rate J can only be measured in the vicinity of this limit (69).
IV.2.2. Polymorphs and phases in droplets
Polymorphs are different solid phases for which the chemical composition is the same.
Moreover, according to Ostwald's rule of states (70) (Figure 8a) . Crystals with this urchinlike habit were previously observed (71, 72) but were not easy to isolate in mL crystallizers. In our droplets, increasing temperature to 30°C dissolved only the sea urchin-like habit (on the right in Figure 8b and 8c) , and not the tetragonal crystal. Thus, we concluded that crystals with a sea-urchin habit are a different phase (73) . Moreover, because of mononuclear nucleation, the nucleated crystal of the metastable phase cannot easily follow a solution-mediated phase transition to a more stable phase. Small volumes of droplets seem to ''freeze'' the metastable phase (74) . Lastly, the higher supersaturations reached in microfluidics, due to volume reduction, increase the probability of nucleating a metastable phase (3, 75) .
In general, even with phases of different compositions, solvates for example, the same phenomena are observed. For instance, we observed in the case of rasburicase that the same experimental conditions produced different crystal habits and phases.
Moreover, the two polymorphs known for rasburicase (76) appeared simultaneously in droplets ( Figure 9 ) (23) . The main reason for this concomitant nucleation is that the difference between their solubilities is weak.
.
IV.3. Nucleation kinetics
The nucleation rate J is the number of crystals that form in the supersaturated solution per unit of volume and per unit of time. To determine J, the Double Pulse Technique (DPT) enables nucleation and growth to be separated (69, 77, 78) . The value of J at a given concentration C, is given by the variation of the number of crystals nucleated, with nucleation time. Therefore, DPT imposes a sequence of temperatures using Tgrowth and Tnucleation respectively chosen to prevent nucleation of crystals and to obtain nucleation of crystals (Figure 7) . The solubility curve and MZ are used to choose Tnucleation to Tgrowth. For instance, for lysozyme (33), TNucleation of 20°C enabled us to compare our data with the data from the literature (78, 79) . TGrowth of 40°C was chosen because it is in the MZ (Figure 7a) . We chose nucleation times under 2h to guarantee that lysozyme concentration was constant in the droplets: after 2h, the growth of nuclei depletes the droplet concentration (33) .
The average number of crystals nucleated per droplet varied linearly with time, confirming steady-state nucleation (Figure 10a) . The steady-state nucleation rate was thus determined by the slope (Figure 10b) . Moreover, straight lines passed through the axis origins except for the highest supersaturation (33) , indicating that the data were not affected by major heterogeneous nucleation (78) . As shown in Figure 10b , our kinetic data are in good agreement with the data of Galkin and Vekilov (5, 78) obtained for the same composition of Lysozyme solution at 12.6°C, using larger droplets (1μL) suspended in Teflon wells. Moreover, the supersaturation range experimentally accessible when the volume of nucleation is reduced to the nL-pL range is increased for kinetic (24) and thermodynamic (80, 81) reasons.
When crystals appear in droplets containing no crystals of that phase, the nucleation is called "primary nucleation" and J is determined by the Classical Nucleation Theory 
V. SCREENING AND OPTIMIZATION OF CRYSTALLIZATION CONDITIONS
Screening and optimizing crystallization conditions of a solute consist in evaluating methods, reagents, and other chemical and physical variables with the objective of producing crystals and/or identifying the variables which are positively or negatively associated with crystallization of the solute. With proteins, a large number of crystallization reagents (buffers, crystallization agents, polymers) are first tested to identify the appropriate combinations of reagents that produce the desired crystal phase. Then, the optimization finely screens concentrations of each reagent in the combination to grow crystals of desired size and quality. For instance, production of large crystals of high quality is crucial in the determination of protein structures by Xray diffraction (XRD).
V.1. Screening of protein crystallization conditions
To screen one or several components in a droplet-based microfluidic system, the flows of components can be mixed directly with the solute flow in a multiport junction (29, 51, 84, 85) yielding droplets of the mixture. However, the change of scale in microfluidic systems influences nucleation kinetics: the smaller the volume the longer the induction time, all things being equal. Thus, the "scale-down" requires generation of higher supersaturation in the droplets, which can lead to precipitation, notably at interfaces created in non-homogeneous droplets (50, 84, 85) . Then, precipitates tend to adhere to the walls of the channels and perturb or even obstruct the flow, with the risk of clogging the channel, one of the major drawbacks in microfluidics (86, 87) . To avoid clogging and ensure higher supersaturation, several microfluidic junctions can be mounted together to successively add reagents to droplets and ensure homogeneity (see part III.3) (30, 51) . Moreover, by increasing the number of inlets, the concentration of each component can be screened.
For instance, a cross-junction is used to mix a protein and a buffer and a T-junction is used to inject a crystallization agent or a ligand for co-crystallization. As the solutions injected into the cross and the T-junctions are miscible, the third solution can be added inside the pre-existing droplets (51).
V.1.1. Screening crystallization agents
Here, we show an example with different crystallization agents of lysozyme prepared in a tubing as a "chemical library" and screened in droplets using a T-junction( Figure   11 ) (30) . The respective flow rates of lysozyme and of "chemical library" were varied so as to keep the size and frequency of droplets constant. Whatever the flow-rate, the two solutions mixed well with the droplets passing through the T-junction, without creating a new interface and thus a new droplet. Moreover, at constant flows, the droplets at the outlet of the T-junction were homogeneous both in size and frequency.
Here, applying our screening strategy to lysozyme led us to select NaCl as crystallization agent to obtain the tetragonal phase (Figure 11c) . Thus, this crystallization condition was used for size optimization using the fine-gradient method (29) (see part V.2.2.).
V.1.2. Screening ligand for co-crystallization
In pharmaceutical research, the co-crystallization of a target protein with many different ligands often enables the identification and design of new active pharmaceutical ingredients. This process is called structure-based drug design (88) . To perform protein-ligand co-crystallization, the protein and the ligand have to be incubated together before supersaturation is generated. First, protein and ligands are mixed in a cross-junction, and second, the crystallization agent is introduced into a T-junction.
The length of the tubing between the cross-and the T-junctions is chosen according to ligand-protein binding affinity (the lower the binding affinity, the longer the tubing).
Ligands are usually only soluble in organic solvents whereas proteins are soluble in aqueous buffers. Thus, mixing ligand and protein solutions requires mixing two different phases during droplet generation. As seen in part III.3., the ligand has to be dissolved in a mixture of organic solvent and water, which improves the stability of the generated droplet (30) .
For instance, for Human quinone reductase 2 (QR2) co-crystallization experiments, we used a known ligand of this protein, melatonin solubilized in DMSO. As the concentration of melatonin required was low (<few mM), it was solubilized by the mixture DMSO and water. Moreover, as proteins are not soluble in organic solvent, the final droplets had to contain no more than 10% organic solvent (89) to avoid disturbing their three-dimensional structure and compromising crystal quality. Thus, adding water to the ligand solutions also reduced the final amount of DMSO in the crystallization droplets, decreasing the risk of protein denaturation.
To validate our microfluidic platform for ligand screening applications, we realized a co-crystallization experiment of QR2 with melatonin in 3 steps (30): First, a 40% DMSO solution with water (without melatonin) was mixed with the protein solution in the crossjunction. The resulting droplets were then mixed with an aqueous solution of crystallization agent in the T-junction so that the final droplets contained 8% DMSO.
The crystals grown in these conditions (Figure 12a ) were similar to those obtained in pure aqueous solution (Figure 12b ) (32) , confirming that DMSO concentration was low enough to preserve the protein structure and its crystallization. Then, QR2 was cocrystallized with melatonin in the 40% DMSO solution leading to crystals (Figure 12c ).
For ligand screening applications, the tubing containing melatonin simply needs to be filled with a "library" of ligands, as in Figure 4 .
V.2. Optimizing crystallization conditions
After selecting a range of reagents through the screening step, optimization proceeds by imposing fine gradients of the concentration of one or several of these reagents.
The optimization of crystallization conditions becomes challenging if viscous precipitants and/or detergents are used.
V.2.1. Optimization in non-viscous solutions
As a simple example, we optimized lysozyme crystallization by varying its concentration in a given buffer. The crystallization conditions were optimized using the fine-gradient method (29): according to screening results (part V.1.1), NaCl buffer and lysozyme solution were injected into a cross-junction face to face (Figure 13 ). The concentration of lysozyme increased with the ratio of the flow rates (lysozyme/NaCl).
Moreover, the respective flow rates were chosen so as to obtain 1 ≤ L/W ≤ 2 (as seen in part III.1), ensuring droplet homogeneity. A wide range of supersaturation was scanned and we obtained large single crystals of protein (Figure 13a-c) (30) .
The fine-gradient method also enables the phase diagram (part IV) to be determined according to the concentration of a crystallization agent. In the case of QR2, we first determined the phase diagram using large volumes according to the concentration of sulfate ammonium. As seen in part IV, Figure 14 (left) shows the solubility curve, the metastable zone and the precipitation zone, where we tested conditions. Figure 14 (right) shows 5 representative droplets out of 60 droplets of 2nl generated in each condition, confirming the phase diagram. Moreover, fine-gradient optimization was used to choose the crystals in Figure 14 for X-ray diffraction (XRD) (32).
V.2.2. Optimization in viscous solution
We explored crystallization in a viscous medium with rasburicase, a biomolecule which crystallizes in polyethylene glycol (PEG) solution, a viscous media (23) . For high concentrations of rasburicase, the addition of a high percentage of PEG led to precipitation at droplet formation. Then, precipitation led to crystals by the Ostwald ripening mechanism (Figure 15a ) (23) . For low concentrations of rasburicase and PEG, no precipitates appeared and nucleation occurred after a few hours, leading to a single crystal (Figure 15b) . Other conditions are shown in Figure 9 with dispersed numbers of crystals and/or phases (23).
V.2.3 Optimization in low interfacial energy solution
For membrane proteins, in addition to PEG as a precipitant, detergents are required to solubilize proteins in water, like C10E5 (Pentaethylene Glycol Monodecyl Ether). For instance, lysozyme was used as model protein (not as complex as membrane proteins)
to demonstrate the handling of viscous and low interfacial energy solutions (29) . To mix these three solutions and generating droplets with a fourth continuous flow, a multiport junction had to be used. Since all droplets were generated using the hydrodynamic operating method (see part III.1) they had identical sizes, frequencies, spacing, etc. Consequently, varying only one ingredient in the same volume of crystallization solution led to comparable and precise mapping in the crystal phase diagram. The parameter which was varied was the concentration of lysozyme. A 5-step concentration gradient of lysozyme (5-15mg/mL) was set by keeping the concentration of PEG and C10E5 constant. The concentration of lysozyme within droplets was verified using online recording of absorbance at 280nm. Almost 200 droplets were generated in tubing of 2m approximate length. The whole droplet trial took less than 1h, consuming only 50µL of lysozyme substrate solution. Droplet incubation and in-situ observation were completed after 24h of incubation at 20°C. We carefully determined the crystal morphogram and mapped the transition from mono-to multi-nucleation of crystals for increasing protein concentrations (Figure 16 ). For instance, mono-nucleation led to the growth of large single crystals (>50µm) (insert in Figure 16 A1, A2 and A3). These optimized conditions could be scaled up to obtain larger crystals for structure determination in X-ray diffraction.
V.3. X-ray diffraction of crystals in droplets
Crystallization is often used to produce large crystals (about 100μm) of high quality, required to determine the nature of the three-dimensional structure of proteins by Xray diffraction (XRD), allowing a better understanding of their biological functions.
However, manual handling of the sample crystals can mechanically and environmentally stress them. The stress induced during this delicate step may affect the quality of the crystal and decrease its diffractive power. To minimize manual handling, an alternative is in-situ X-ray data collection. One approach involves using X-ray-transparent microfluidic devices (90) (91) (92) (93) (94) (95) (96) (97) (98) (99) . Another solution, following the pioneering work of Yadav et al. (100) , is to collect X-ray data directly in a micro-capillary 
V.3.1. In-situ XRD
In droplet-based microfluidic systems, droplets are easily generated and stabilized in
Teflon tubing due to the non-wettability of Teflon with many solutions (aqueous and mixed aqueous and organic) and to its wettability with the continuous flow (oil). Crystals thus nucleate in droplets stored in Teflon tubing. However, Teflon-related background noise is significant in the diffraction patterns. This reduces the quality of the diffraction data (100) and strongly reduces the observed diffraction limits of the crystals.
Therefore, we transferred droplets containing the crystals of interest from tubing in
Teflon to tubing in silica for in-situ XRD without cooling.
In the case of QR2 crystals obtained after screening and optimizing crystallization conditions (see part V.2.1.), we transferred the droplets from experiment (Figure 14b) to silica tubing. The internal silica tubing wall was coated with a commercial hydrophobic surface-coating agent to ensure droplet stability. The silica tubing containing the droplets was directly mounted on a magnetic base extracted from standard SPINE sample loops, ready for transfer to the X-ray setup (Figure 17a) . A crystal of Figure 14b analyzed by XRD at room temperature gave diffraction to a resolution of 2,7Å (32), enabling the space group of the crystal to be determined. It was in accordance with space groups reported in the literature (103) , regardless of whether we used cryogenic conditions or not.
V.3.2. Ex-situ XRD
As crystals of QR2 were stored in droplets in Teflon tubing (Figure 14b ), they were deposited on a MicroMesh using a high-precision micro-injector for flow control and micromanipulators for precise displacement in X, Y and Z (104). The crystals were placed singly on the MicroMesh (Figure 17b) , which was immediately extracted from the oil bath and immersed in liquid nitrogen to cryogenize the crystals. For cryoprotection, either the oil acted as a cryo-protectant, or crystals were immersed in a drop of glycerol. Thus, the crystals were extracted without direct handling or mechanical stress and prepared for diffraction studies under cryogenic conditions.
Their analysis by XRD with or without glycerol gave diffraction to a resolution of 2,3Å (32) .
Finally, the crystals obtained after screening and optimization of crystallization conditions were characterized by both in-situ and ex-situ X-ray diffraction. A complete data set was obtained from several crystals of high quality, due to strong X-ray damage to crystals, notably at room temperature. Nevertheless, as microfluidics yields hundreds to thousands of droplets with identical composition, serial crystallography at room temperature would yield a complete set of data for structural resolution with limited noticeable effects from radiation damage (97).
CONCLUSION
This review compares droplet-based microfluidic systems used to study biomolecule Droplets were first generated at a temperature chosen to prevent nucleation of crystals, Tgrowth.
Then the temperature was lowered to Tnucleation to obtain nucleation of crystals. After a period of Δt (nucleation time), temperature was raised from Tnucleation to Tgrowth. At Tgrowth, supersaturation was at a level where the nucleation rate was practically zero, but the crystals already formed could grow to detectable dimensions. After the growth stage, the crystals 
